+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment

Comparison of CT and chemical-shift MRI for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and quantitative assessment

Clinical Radiology 71(3): E157

To evaluate the usefulness of computed tomography (CT) and chemical-shift magnetic resonance imaging (MRI) in patients with myasthenia gravis (MG) for differentiating thymoma (THY) from thymic lymphoid hyperplasia (TLH) and normal thymus (NT), and to determine which technique is more accurate. Eighty-three patients with generalised MG who underwent surgery were divided into the TLH/NT group (A; 65 patients) and THY group (B; 24 patients). Differences in qualitative characteristics and quantitative data (CT: radiodensity in Hounsfield units; MRI: signal intensity index [SII]) between groups were tested using Fisher's exact test and Student's t-test. Logistic regression models were estimated for both qualitative and quantitative analyses. At quantitative analysis, discrimination abilities were determined according to the area under the receiver operating characteristic (ROC) curve (AUROC) with computation of optimal cut-off points. The diagnostic accuracies of CT and MRI were compared using McNemar's test. At qualitative assessment, MRI had higher accuracy than CT (96.4%, 80/83 and 86.7%, 72/83, respectively). At quantitative analysis, both the radiodensity and SII were significantly different between groups (p<0.0001). For CT, at quantitative assessment, the AUROC of the radiodensity in discriminating between groups was 0.904 (optimal cut-off point, 20 HU) with an accuracy of 77.1% (64/83). For MRI, the AUROC of the SII was 0.989 (optimal cut-off point, 7.766%) with an accuracy of 96.4% (80/83), which was significantly higher than CT (p<0.0001). By using optimal cut-off points for cases with an erroneous diagnosis at qualitative assessment, accuracy improved both for CT (89.2%, 74/83) and MRI (97.6%, 81/83). Quantitative analysis is useful in evaluating patients with MG and improves the diagnostic accuracy of CT and MRI based on qualitative assessment. Chemical-shift MRI is more reliable than CT in differentiating THYs from non-thymomatous conditions.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057463080

Download citation: RISBibTeXText

PMID: 26774127

DOI: 10.1016/j.crad.2015.12.009

Related references

Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis. Interactive Cardiovascular and Thoracic Surgery 18(4): 475-481, 2014

Myasthenia gravis with thymoma: analysis of and postoperative prognosis for 65 patients with thymomatous myasthenia gravis. Annals of Thoracic Surgery 38(1): 46-52, 1984

Chemical-shift and diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative assessment. Investigative Radiology 50(4): 228-238, 2015

Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969. American Journal of Medicine 50(4): 465-474, 1971

Comparison of thymectomy with conservative treatment in autoimmune non-thymomatous myasthenia gravis. 2007

Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors. European Journal of Cardio-Thoracic Surgery 37(1): 7-12, 2010

Thymomatous myasthenia gravis. Gaoxiong Yi Xue Ke Xue Za Zhi 4(5): 273-284, 1988

Post-thymomectomy myasthenia gravis. Report of a case of ocular myasthenia gravis after total removal of a thymoma and review of literature. Neurology 17(4): 413-420, 1967

Pemphigus foliaceus, myasthenia gravis, thymoma and red cell aplasia. A case report and indirect immunofluorescence study on 38 patients with myasthenia gravis. Clinical and Experimental Dermatology 3(3): 285-291, 1978

Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database of Systematic Reviews 2013(10): Cd008111, 2013

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis. Journal of Neurology 251(8): 1006-1011, 2004

Is thymectomy in non-thymomatous myasthenia gravis of any benefit?. Interactive Cardiovascular and Thoracic Surgery 18(3): 381-389, 2014

Rethymectomy in patients with non-thymomatous myasthenia gravis. 2007

A case of thymomatous myasthenia gravis with an interesting clinical course. Nihon Kyobu Geka Gakkai 35(1): 111-114, 1987